Philippe Nuss

Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes

Ahcène Hameg, Franck Baylé, Philippe Nuss et al. · Biochemical Pharmacology · 2003 · 185 citations · Full text

Human Recombinant Dopamine, Anxiolytic Antipsychotic Drug, Psychoactive Drug +12

A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian)

Yann Hodé, Matthias Reimold, A. Demazières et al. · Psychopharmacology · 2005 · 174 citations

Positron Emission Tomography, Psychopharmacology, Neuropharmacology +8

Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations

Christian Tessier, Kim Sweers, Ariel Frajerman et al. · Translational Psychiatry · 2016 · 94 citations · Full text

Neuropsychology, Neuropsychiatry, Cognitive Manifestations +18

The interaction of antipsychotic drugs with lipids and subsequent lipid reorganization investigated using biophysical methods

Isabel D. Alves, Galya Staneva, Cédric Tessier et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2011 · 39 citations

Lipid Preparation, Medicine, Psychotropic Medication +8

Modification of membrane heterogeneity by antipsychotic drugs: An X-ray diffraction comparative study

Cédric Tessier, Philippe Nuss, Galya Staneva et al. · Journal of Colloid and Interface Science · 2008 · 38 citations

Membrane Formation, Biochemistry, Medicine +6